Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Myelodysplastic Syndrome with Excess Blasts — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Myeloid Neoplasm
Myelodysplastic Syndrome
Myelodysplastic Syndrome with Excess Blasts

Hematologic Malignancy

Myelodysplastic Syndrome with Excess Blasts

CI-CAN-00003369MDS-EB · MDS-IB · RAEB · RAEB-1Explore in graph →

Hematologic23 active trials

NCIt: C7506
OncoTree: MDSEB
UMLS CUI: C1318550

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials76
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

76 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 23
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

StatusAll Active (any)Completed 40 Recruiting 13 Active Not Recruiting 9 Terminated 8 Unknown 2 Not Yet Recruiting 2 Withdrawn 1 Suspended 1

PhaseAll N/A 2 Phase 1 35 Phase 2 41 Phase 3 7 Phase 4 1

No study matches these filters